BioNTech SE: xbrl:CashFlowsFromUsedInFinancingActivities
| Value | {"unit": "EUR", "value": -778600000} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | BioNTech SE |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/fa6b6fe9-24a2-47a5-9143-594d19ab95f9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001776985-24-000027Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/fa6b6fe9-24a2-47a5-9143-594d19ab95f9
History
- no predecessors — first report